[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Synthetic Type Colloids (Blood Plasma) Market Report 2017

January 2017 | 122 pages | ID: UF6CE732709EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Synthetic Type Colloids (Blood Plasma)

Revenue, means the sales value of Synthetic Type Colloids (Blood Plasma)

This report studies sales (consumption) of Synthetic Type Colloids (Blood Plasma) in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • CSL Behring
  • Baxter
  • Grifols
  • Octapharma
  • Kedrion
  • Shanghai Raas
  • CTBB
  • Hualan Bio
  • Rongsheng Pharmaceutical
  • Boya Rongsheng
Market Segment by States, covering
  • California
  • Texas
  • New York
  • Florida
  • Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Gelatins
  • Dextrans
  • Starches
  • Other
Split by applications, this report focuses on sales, market share and growth rate of Synthetic Type Colloids (Blood Plasma) in each application, can be divided into
  • Extensive Burns
  • Massive Blood or Plasma Loss
  • Hypovolemic Shock
  • Others
United States Synthetic Type Colloids (Blood Plasma) Market Report 2017

1 SYNTHETIC TYPE COLLOIDS (BLOOD PLASMA) OVERVIEW

1.1 Product Overview and Scope of Synthetic Type Colloids (Blood Plasma)
1.2 Classification of Synthetic Type Colloids (Blood Plasma)
  1.2.1 Gelatins
  1.2.2 Dextrans
  1.2.3 Starches
  1.2.4 Other
1.3 Application of Synthetic Type Colloids (Blood Plasma)
  1.3.1 Extensive Burns
  1.3.2 Massive Blood or Plasma Loss
  1.3.3 Hypovolemic Shock
  1.3.4 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Synthetic Type Colloids (Blood Plasma) (2012-2022)
  1.4.1 United States Synthetic Type Colloids (Blood Plasma) Sales and Growth Rate (2012-2022)
  1.4.2 United States Synthetic Type Colloids (Blood Plasma) Revenue and Growth Rate (2012-2022)

2 UNITED STATES SYNTHETIC TYPE COLLOIDS (BLOOD PLASMA) COMPETITION BY MANUFACTURERS

2.1 United States Synthetic Type Colloids (Blood Plasma) Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Synthetic Type Colloids (Blood Plasma) Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Synthetic Type Colloids (Blood Plasma) Average Price by Manufactures (2015 and 2016)
2.4 Synthetic Type Colloids (Blood Plasma) Market Competitive Situation and Trends
  2.4.1 Synthetic Type Colloids (Blood Plasma) Market Concentration Rate
  2.4.2 Synthetic Type Colloids (Blood Plasma) Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES SYNTHETIC TYPE COLLOIDS (BLOOD PLASMA) SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Synthetic Type Colloids (Blood Plasma) Sales and Market Share by States (2012-2017)
3.2 United States Synthetic Type Colloids (Blood Plasma) Revenue and Market Share by States (2012-2017)
3.3 United States Synthetic Type Colloids (Blood Plasma) Price by States (2012-2017)

4 UNITED STATES SYNTHETIC TYPE COLLOIDS (BLOOD PLASMA) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Synthetic Type Colloids (Blood Plasma) Sales and Market Share by Type (2012-2017)
4.2 United States Synthetic Type Colloids (Blood Plasma) Revenue and Market Share by Type (2012-2017)
4.3 United States Synthetic Type Colloids (Blood Plasma) Price by Type (2012-2017)
4.4 United States Synthetic Type Colloids (Blood Plasma) Sales Growth Rate by Type (2012-2017)

5 UNITED STATES SYNTHETIC TYPE COLLOIDS (BLOOD PLASMA) SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Synthetic Type Colloids (Blood Plasma) Sales and Market Share by Application (2012-2017)
5.2 United States Synthetic Type Colloids (Blood Plasma) Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES SYNTHETIC TYPE COLLOIDS (BLOOD PLASMA) MANUFACTURERS PROFILES/ANALYSIS

6.1 CSL Behring
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Synthetic Type Colloids (Blood Plasma) Product Type, Application and Specification
    6.1.2.1 Gelatins
    6.1.2.2 Dextrans
  6.1.3 CSL Behring Synthetic Type Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Baxter
  6.2.2 Synthetic Type Colloids (Blood Plasma) Product Type, Application and Specification
    6.2.2.1 Gelatins
    6.2.2.2 Dextrans
  6.2.3 Baxter Synthetic Type Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Grifols
  6.3.2 Synthetic Type Colloids (Blood Plasma) Product Type, Application and Specification
    6.3.2.1 Gelatins
    6.3.2.2 Dextrans
  6.3.3 Grifols Synthetic Type Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Octapharma
  6.4.2 Synthetic Type Colloids (Blood Plasma) Product Type, Application and Specification
    6.4.2.1 Gelatins
    6.4.2.2 Dextrans
  6.4.3 Octapharma Synthetic Type Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Kedrion
  6.5.2 Synthetic Type Colloids (Blood Plasma) Product Type, Application and Specification
    6.5.2.1 Gelatins
    6.5.2.2 Dextrans
  6.5.3 Kedrion Synthetic Type Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Shanghai Raas
  6.6.2 Synthetic Type Colloids (Blood Plasma) Product Type, Application and Specification
    6.6.2.1 Gelatins
    6.6.2.2 Dextrans
  6.6.3 Shanghai Raas Synthetic Type Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 CTBB
  6.7.2 Synthetic Type Colloids (Blood Plasma) Product Type, Application and Specification
    6.7.2.1 Gelatins
    6.7.2.2 Dextrans
  6.7.3 CTBB Synthetic Type Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Hualan Bio
  6.8.2 Synthetic Type Colloids (Blood Plasma) Product Type, Application and Specification
    6.8.2.1 Gelatins
    6.8.2.2 Dextrans
  6.8.3 Hualan Bio Synthetic Type Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Rongsheng Pharmaceutical
  6.9.2 Synthetic Type Colloids (Blood Plasma) Product Type, Application and Specification
    6.9.2.1 Gelatins
    6.9.2.2 Dextrans
  6.9.3 Rongsheng Pharmaceutical Synthetic Type Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Boya Rongsheng
  6.10.2 Synthetic Type Colloids (Blood Plasma) Product Type, Application and Specification
    6.10.2.1 Gelatins
    6.10.2.2 Dextrans
  6.10.3 Boya Rongsheng Synthetic Type Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 SYNTHETIC TYPE COLLOIDS (BLOOD PLASMA) MANUFACTURING COST ANALYSIS

7.1 Synthetic Type Colloids (Blood Plasma) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Synthetic Type Colloids (Blood Plasma)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Synthetic Type Colloids (Blood Plasma) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Synthetic Type Colloids (Blood Plasma) Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES SYNTHETIC TYPE COLLOIDS (BLOOD PLASMA) MARKET FORECAST (2017-2022)

11.1 United States Synthetic Type Colloids (Blood Plasma) Sales, Revenue Forecast (2017-2022)
11.2 United States Synthetic Type Colloids (Blood Plasma) Sales Forecast by Type (2017-2022)
11.3 United States Synthetic Type Colloids (Blood Plasma) Sales Forecast by Application (2017-2022)
11.4 Synthetic Type Colloids (Blood Plasma) Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Synthetic Type Colloids (Blood Plasma)
Table Classification of Synthetic Type Colloids (Blood Plasma)
Figure United States Sales Market Share of Synthetic Type Colloids (Blood Plasma) by Type in 2015
Figure Gelatins Picture
Figure Dextrans Picture
Figure Starches Picture
Figure Other Picture
Table Application of Synthetic Type Colloids (Blood Plasma)
Figure United States Sales Market Share of Synthetic Type Colloids (Blood Plasma) by Application in 2015
Figure Extensive Burns Examples
Figure Massive Blood or Plasma Loss Examples
Figure Hypovolemic Shock Examples
Figure Others Examples
Figure United States Synthetic Type Colloids (Blood Plasma) Sales and Growth Rate (2012-2022)
Figure United States Synthetic Type Colloids (Blood Plasma) Revenue and Growth Rate (2012-2022)
Table United States Synthetic Type Colloids (Blood Plasma) Sales of Key Manufacturers (2015 and 2016)
Table United States Synthetic Type Colloids (Blood Plasma) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Synthetic Type Colloids (Blood Plasma) Sales Share by Manufacturers
Figure 2016 Synthetic Type Colloids (Blood Plasma) Sales Share by Manufacturers
Table United States Synthetic Type Colloids (Blood Plasma) Revenue by Manufacturers (2015 and 2016)
Table United States Synthetic Type Colloids (Blood Plasma) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Synthetic Type Colloids (Blood Plasma) Revenue Share by Manufacturers
Table 2016 United States Synthetic Type Colloids (Blood Plasma) Revenue Share by Manufacturers
Table United States Market Synthetic Type Colloids (Blood Plasma) Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Synthetic Type Colloids (Blood Plasma) Average Price of Key Manufacturers in 2015
Figure Synthetic Type Colloids (Blood Plasma) Market Share of Top 3 Manufacturers
Figure Synthetic Type Colloids (Blood Plasma) Market Share of Top 5 Manufacturers
Table United States Synthetic Type Colloids (Blood Plasma) Sales by States (2012-2017)
Table United States Synthetic Type Colloids (Blood Plasma) Sales Share by States (2012-2017)
Figure United States Synthetic Type Colloids (Blood Plasma) Sales Market Share by States in 2015
Table United States Synthetic Type Colloids (Blood Plasma) Revenue and Market Share by States (2012-2017)
Table United States Synthetic Type Colloids (Blood Plasma) Revenue Share by States (2012-2017)
Figure Revenue Market Share of Synthetic Type Colloids (Blood Plasma) by States (2012-2017)
Table United States Synthetic Type Colloids (Blood Plasma) Price by States (2012-2017)
Table United States Synthetic Type Colloids (Blood Plasma) Sales by Type (2012-2017)
Table United States Synthetic Type Colloids (Blood Plasma) Sales Share by Type (2012-2017)
Figure United States Synthetic Type Colloids (Blood Plasma) Sales Market Share by Type in 2015
Table United States Synthetic Type Colloids (Blood Plasma) Revenue and Market Share by Type (2012-2017)
Table United States Synthetic Type Colloids (Blood Plasma) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Synthetic Type Colloids (Blood Plasma) by Type (2012-2017)
Table United States Synthetic Type Colloids (Blood Plasma) Price by Type (2012-2017)
Figure United States Synthetic Type Colloids (Blood Plasma) Sales Growth Rate by Type (2012-2017)
Table United States Synthetic Type Colloids (Blood Plasma) Sales by Application (2012-2017)
Table United States Synthetic Type Colloids (Blood Plasma) Sales Market Share by Application (2012-2017)
Figure United States Synthetic Type Colloids (Blood Plasma) Sales Market Share by Application in 2015
Table United States Synthetic Type Colloids (Blood Plasma) Sales Growth Rate by Application (2012-2017)
Figure United States Synthetic Type Colloids (Blood Plasma) Sales Growth Rate by Application (2012-2017)
Table CSL Behring Basic Information List
Table CSL Behring Synthetic Type Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CSL Behring Synthetic Type Colloids (Blood Plasma) Sales Market Share (2012-2017)
Table Baxter Basic Information List
Table Baxter Synthetic Type Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Baxter Synthetic Type Colloids (Blood Plasma) Sales Market Share (2012-2017)
Table Grifols Basic Information List
Table Grifols Synthetic Type Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Grifols Synthetic Type Colloids (Blood Plasma) Sales Market Share (2012-2017)
Table Octapharma Basic Information List
Table Octapharma Synthetic Type Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Octapharma Synthetic Type Colloids (Blood Plasma) Sales Market Share (2012-2017)
Table Kedrion Basic Information List
Table Kedrion Synthetic Type Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Kedrion Synthetic Type Colloids (Blood Plasma) Sales Market Share (2012-2017)
Table Shanghai Raas Basic Information List
Table Shanghai Raas Synthetic Type Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Shanghai Raas Synthetic Type Colloids (Blood Plasma) Sales Market Share (2012-2017)
Table CTBB Basic Information List
Table CTBB Synthetic Type Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2012-2017)
Table CTBB Synthetic Type Colloids (Blood Plasma) Sales Market Share (2012-2017)
Table Hualan Bio Basic Information List
Table Hualan Bio Synthetic Type Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Hualan Bio Synthetic Type Colloids (Blood Plasma) Sales Market Share (2012-2017)
Table Rongsheng Pharmaceutical Basic Information List
Table Rongsheng Pharmaceutical Synthetic Type Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Rongsheng Pharmaceutical Synthetic Type Colloids (Blood Plasma) Sales Market Share (2012-2017)
Table Boya Rongsheng Basic Information List
Table Boya Rongsheng Synthetic Type Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Boya Rongsheng Synthetic Type Colloids (Blood Plasma) Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Synthetic Type Colloids (Blood Plasma)
Figure Manufacturing Process Analysis of Synthetic Type Colloids (Blood Plasma)
Figure Synthetic Type Colloids (Blood Plasma) Industrial Chain Analysis
Table Raw Materials Sources of Synthetic Type Colloids (Blood Plasma) Major Manufacturers in 2015
Table Major Buyers of Synthetic Type Colloids (Blood Plasma)
Table Distributors/Traders List
Figure United States Synthetic Type Colloids (Blood Plasma) Production and Growth Rate Forecast (2017-2022)
Figure United States Synthetic Type Colloids (Blood Plasma) Revenue and Growth Rate Forecast (2017-2022)
Table United States Synthetic Type Colloids (Blood Plasma) Production Forecast by Type (2017-2022)
Table United States Synthetic Type Colloids (Blood Plasma) Consumption Forecast by Application (2017-2022)
Table United States Synthetic Type Colloids (Blood Plasma) Sales Forecast by States (2017-2022)
Table United States Synthetic Type Colloids (Blood Plasma) Sales Share Forecast by States (2017-2022)


More Publications